IPS’s Oncology Department Launches New Insights

IPS’s Oncology department has commenced a new, exciting insight-gathering project with a top-10 Pharmaceutical company. The objective is to better understand prescribing preferences within the U.S. cancer market.

Leveraging IPS’s innovative Scientific Pulse™ platform, the project will aid in identifying and engaging hundreds of U.S.-based oncologists throughout 2025. IPS has a proven track record of delivering best-in-class research, setting the gold standard for insights generation within the global pharmaceutical and life sciences industries.

‍